当前位置: 首页 >> 检索结果
共有 6613 条符合本次的查询结果, 用时 5.5182401 秒

441. Response.

作者: Sean Kalra.;Michael H Cho.;Matthew Moll.
来源: Chest. 2025年168卷1期e22-e23页

442. Response.

作者: Junichi Izawa.
来源: Chest. 2025年168卷1期e21-e22页

443. On the Many Ways in Which Paco2 Levels Can Influence Survival for Patients Treated With Extracorporeal CPR.

作者: Maxwell A Hockstein.;Joseph E Tonna.
来源: Chest. 2025年168卷1期e20-e21页

444. Response.

作者: Aditya C Shekhar.;Michael McCartin.;Timothy Friedmann.;Graham Sabo.;Jacob Stebel.;Joshua Kimbrell.;Bojana Milekic.;Ethan Abbott.;Ira J Blumen.
来源: Chest. 2025年168卷1期e19-e20页

445. Enhancing Prehospital Cricothyrotomy: Addressing Gaps in Indications, Outcomes, and Techniques.

作者: Yalcin Gölcük.
来源: Chest. 2025年168卷1期e18-e19页

446. Response.

作者: Marko Nemet.;Cameron G Gmehlin.;Marija Vukoja.;Yue Dong.;Ognjen Gajic.;Aysun Tekin.
来源: Chest. 2025年168卷1期e17-e18页

447. Driving Health Care Reform to Combat Ventilator-Associated Pneumonia in Low-Resource Settings.

作者: Yumei Zhong.;Shanshan Liu.;Xiaofeng Lv.
来源: Chest. 2025年168卷1期e16-e17页

448. Do Eosinopenic Patients With Community-Acquired Pneumonia Really Have a Worse Outcome?

作者: Ali Kirac.;Celal Satici.
来源: Chest. 2025年168卷1期e15页

449. Response.

作者: Barbara Christine Weckler.;Bernd Schmeck.
来源: Chest. 2025年168卷1期e15-e16页

450. Sudden Right Lower Limb Paralysis: An Uncommon Presentation of Type A Aortic Dissection.

作者: Xiangxin Wang.;Zhuoqi Li.
来源: Chest. 2025年168卷1期e1-e2页
Acute aortic dissection is a rare and life-threatening emergency, with fatal outcomes often resulting from delayed or missed diagnoses. Type A aortic dissection, which typically presents with acute chest pain radiating to the back, is the most common cause of death associated with aortic lesions and requires urgent surgical intervention. We present an unusual case of type A aortic dissection that manifested solely with sudden paralysis and tingling of the right lower limb, without chest or back pain. Despite timely diagnosis in the emergency department, emergency surgical intervention failed to save the patient's life.

451. Pursuing Precision for a Persistent Issue in the Diagnosis of Neuroendocrine Cell Hyperplasia of Infancy.

作者: Telford Yeung.;Israel Amirav.
来源: Chest. 2025年168卷1期8-9页

452. Gender Inequities in Academic Medicine: Peer Review and Beyond.

作者: Rachel Kohn.;Meeta Prasad Kerlin.
来源: Chest. 2025年168卷1期6-7页

453. To Leak, or Not to Leak: Is That Really the Question?

作者: Dan Perri.;Thomas Piraino.
来源: Chest. 2025年168卷1期4-5页

454. Cardiopulmonary Imaging With 0.55T MRI.

作者: Felicia Seemann.;Adrienne E Campbell-Washburn.
来源: Chest. 2025年168卷1期16-18页

455. Measuring Activity in Pediatric Pulmonary Hypertension: Expanding Opportunities to Advance Clinical Trial Design and Impact.

作者: Eric D Austin.
来源: Chest. 2025年168卷1期13-15页

456. When Heartburn Meets Heart Failure: H2 Antagonism in Pulmonary Arterial Hypertension as a Potential Right Ventricular Remedy.

作者: Leo Godzecki.;Mardi Gomberg-Maitland.
来源: Chest. 2025年168卷1期10-12页

457. Low-Tidal-Volume Ventilation and Mortality in Patients With Acute Brain Injury: A Secondary Analysis of an International Observational Study.

作者: Julian F Daza.;Doulia M Hamad.;Martin Urner.;Kuan Liu.;Sarah Wahlster.;Chiara Robba.;Robert D Stevens.;Victoria A McCredie.;Raphael Cinotti.;Shaurya Taran.; .; .; .; .; .; .
来源: Chest. 2025年168卷5期1141-1151页
Low-tidal-volume ventilation (LTVV) improves outcomes in critically ill patients, but its impact in patients with acute brain injuries (ABIs) is less certain.

458. The Influence of Hospital Policies on Clinicians' Decisions to Withhold or Withdraw Life-Sustaining Treatment.

作者: Gina M Piscitello.;Edlyn Lopez Wolwowicz.;Michael T Huber.;Kelly C Vranas.;Donald R Sullivan.;Katrina E Hauschildt.;Patrick G Lyons.
来源: Chest. 2025年168卷6期1446-1458页
There is considerable variation in clinicians' approaches to decisions to withhold or withdraw life-sustaining treatment (LST) across US hospitals. These differences are not explained by patient preferences alone and are likely influenced by other factors (eg, hospital policies, hospital culture, state laws, medical society guidelines).

459. The Impact of the Unknown: Patient Experiences With Uncertainty in Sarcoidosis.

作者: Kristen R Mathias.;Michelle N Eakin.;Katrina E Hauschildt.;Edward S Chen.;Nisha A Gilotra.;Nancy W Lin.;Catherine A Bonham.;Michelle Sharp.
来源: Chest. 2025年168卷6期1395-1403页
Individuals with sarcoidosis face many sources of illness uncertainty, including diagnostic delays, unpredictable therapeutic efficacy and toxicity, and disease-associated morbidity and mortality. Patient perspectives on illness uncertainty in sarcoidosis have not been evaluated critically and offer an opportunity for providers to contextualize and prioritize gaps in care and patient support.

460. Beryllium Lymphocyte Proliferation Test: Differential Diagnosis of Sarcoidosis and Chronic Beryllium Disease.

作者: Louis Jouanjan.;Charlott Terschluse.;Gernot Zissel.;Prerana Agarwal.;Emil Wachenfeld.;Caroline Quartucci.;Daniel Soriano.;Joachim Müller-Quernheim.;Daiana Stolz.;Björn C Frye.
来源: Chest. 2025年168卷6期1404-1414页
Chronic beryllium disease (CBD) is considered a phenocopy of sarcoidosis, generally caused by occupational exposure to beryllium. Its diagnosis relies on the demonstration of beryllium sensitization by the beryllium lymphocyte proliferation test (BeLPT).
共有 6613 条符合本次的查询结果, 用时 5.5182401 秒